Cargando…
parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism
BACKGROUND: parkin mutations are a common cause of parkinsonism. Possessing two parkin mutations leads to early-onset parkinsonism, while having one mutation may predispose to late-onset disease. This dosage pattern suggests that some parkin families should exhibit intergenerational variation in age...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551608/ https://www.ncbi.nlm.nih.gov/pubmed/15725358 http://dx.doi.org/10.1186/1471-2377-5-4 |
_version_ | 1782122472917696512 |
---|---|
author | Poorkaj, Parvoneh Moses, Lina Montimurro, Jennifer S Nutt, John G Schellenberg, Gerard D Payami, Haydeh |
author_facet | Poorkaj, Parvoneh Moses, Lina Montimurro, Jennifer S Nutt, John G Schellenberg, Gerard D Payami, Haydeh |
author_sort | Poorkaj, Parvoneh |
collection | PubMed |
description | BACKGROUND: parkin mutations are a common cause of parkinsonism. Possessing two parkin mutations leads to early-onset parkinsonism, while having one mutation may predispose to late-onset disease. This dosage pattern suggests that some parkin families should exhibit intergenerational variation in age at onset resembling anticipation. A subset of familial PD exhibits anticipation, the cause of which is unknown. The aim of this study was to determine if anticipation was due to parkin mutation dosage. METHODS: We studied 19 kindreds that had early-onset parkinsonism in the offspring generation, late-onset parkinsonism in the parent generation, and ≥ 20 years of anticipation. We also studied 28 early-onset parkinsonism cases without anticipation. Patients were diagnosed by neurologists at a movement disorder clinic. parkin analysis included sequencing and dosage analysis of all 12 exons. RESULTS: Only one of 19 cases had compound parkin mutations, but contrary to our postulate, the affected relative with late-onset parkinsonism did not have a parkin mutation. In effect, none of the anticipation cases could be attributed to parkin. In contrast, 21% of early-onset parkinsonism patients without anticipation had parkin mutations. CONCLUSION: Anticipation is not linked to parkin, and may signify a distinct disease entity. |
format | Text |
id | pubmed-551608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-5516082005-03-04 parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism Poorkaj, Parvoneh Moses, Lina Montimurro, Jennifer S Nutt, John G Schellenberg, Gerard D Payami, Haydeh BMC Neurol Research Article BACKGROUND: parkin mutations are a common cause of parkinsonism. Possessing two parkin mutations leads to early-onset parkinsonism, while having one mutation may predispose to late-onset disease. This dosage pattern suggests that some parkin families should exhibit intergenerational variation in age at onset resembling anticipation. A subset of familial PD exhibits anticipation, the cause of which is unknown. The aim of this study was to determine if anticipation was due to parkin mutation dosage. METHODS: We studied 19 kindreds that had early-onset parkinsonism in the offspring generation, late-onset parkinsonism in the parent generation, and ≥ 20 years of anticipation. We also studied 28 early-onset parkinsonism cases without anticipation. Patients were diagnosed by neurologists at a movement disorder clinic. parkin analysis included sequencing and dosage analysis of all 12 exons. RESULTS: Only one of 19 cases had compound parkin mutations, but contrary to our postulate, the affected relative with late-onset parkinsonism did not have a parkin mutation. In effect, none of the anticipation cases could be attributed to parkin. In contrast, 21% of early-onset parkinsonism patients without anticipation had parkin mutations. CONCLUSION: Anticipation is not linked to parkin, and may signify a distinct disease entity. BioMed Central 2005-02-22 /pmc/articles/PMC551608/ /pubmed/15725358 http://dx.doi.org/10.1186/1471-2377-5-4 Text en Copyright © 2005 Poorkaj et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Poorkaj, Parvoneh Moses, Lina Montimurro, Jennifer S Nutt, John G Schellenberg, Gerard D Payami, Haydeh parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism |
title | parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism |
title_full | parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism |
title_fullStr | parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism |
title_full_unstemmed | parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism |
title_short | parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism |
title_sort | parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551608/ https://www.ncbi.nlm.nih.gov/pubmed/15725358 http://dx.doi.org/10.1186/1471-2377-5-4 |
work_keys_str_mv | AT poorkajparvoneh parkinmutationdosageandthephenomenonofanticipationamoleculargeneticstudyoffamilialparkinsonism AT moseslina parkinmutationdosageandthephenomenonofanticipationamoleculargeneticstudyoffamilialparkinsonism AT montimurrojennifers parkinmutationdosageandthephenomenonofanticipationamoleculargeneticstudyoffamilialparkinsonism AT nuttjohng parkinmutationdosageandthephenomenonofanticipationamoleculargeneticstudyoffamilialparkinsonism AT schellenberggerardd parkinmutationdosageandthephenomenonofanticipationamoleculargeneticstudyoffamilialparkinsonism AT payamihaydeh parkinmutationdosageandthephenomenonofanticipationamoleculargeneticstudyoffamilialparkinsonism |